Biodegradable colloidal particles for inhalative administration
Inhalative administration is an important method of application for medications and active ingredients for the treatment of pulmonary diseases.<br><br>
Now nanoparticular transport vehicles are available, which absorb active ingredients and release them at the desired location, i.e. the lungs. In particular, these are biodegradable particles, which are composed of a biologically degradable amphiphilic comb polymer, which is based on a polyol backbone with positively charged side chains. The biodegradable particles are suitable for simple and patient-friendly application, in particular for inhalative administration of pharmaceutical agents for the treatment of diseases in humans and higher mammals.<br><br> The particles remain stable during the process of aerosol production, i.e. through nebulisation and release the agents continuously after deposition in the lungs, whereby a constant drug level is ensured. It is of particular advantage that, due to this targeted administration of pharmaceutical agents, the number of necessary inhalations can be considerably reduced.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Parallel Paths: Understanding Malaria Resistance in Chimpanzees and Humans
The closest relatives of humans adapt genetically to habitats and infections Survival of the Fittest: Genetic Adaptations Uncovered in Chimpanzees Görlitz, 10.01.2025. Chimpanzees have genetic adaptations that help them survive…
You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation
The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…
Trust Your Gut—RNA-Protein Discovery for Better Immunity
HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…